<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Spillantini, M.G.</title>
    <link>http://repub.eur.nl/res/aut/10247/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (Article)</title>
      <link>http://repub.eur.nl/res/pub/19229/</link>
      <pubDate>2010-03-01T00:00:00Z</pubDate>
      <description>Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. The predominant neuropathology is FTLD with TAR DNA-binding protein (TDP-43) inclusions (FTLD-TDP). FTLD-TDP is frequently familial, resulting from mutations in GRN (which encodes progranulin). We assembled an international collaboration to identify susceptibility loci for FTLD-TDP through a genome-wide association study of 515 individuals with FTLD-TDP. We found that FTLD-TDP associates with multiple SNPs mapping to a single linkage disequilibrium block on 7p21 that contains TMEM106B. Three SNPs retained genome-wide significance following Bonferroni correction (top SNP rs1990622, P = 1.08 × 10 11; odds ratio, minor allele (C) 0.61, 95% CI 0.53-0.71). The association replicated in 89 FTLD-TDP cases (rs1990622; P = 2 × 10 4). TMEM106B variants may confer risk of FTLD-TDP by increasing TMEM106B expression. TMEM106B variants also contribute to genetic risk for FTLD-TDP in individuals with mutations in GRN. Our data implicate variants in TMEM106B as a strong risk factor for FTLD-TDP, suggesting an underlying pathogenic mechanism.</description>
    </item> <item>
      <title>Hereditary frontotemporal dementia caused by Tau gene mutations (Article)</title>
      <link>http://repub.eur.nl/res/pub/36721/</link>
      <pubDate>2007-01-01T00:00:00Z</pubDate>
      <description>Tau protein is involved in microtubule assembly and stabilization. Filamentous deposits made of tau constitute a defining characteristic of several neurodegenerative diseases. The relevance of tau dysfunction for neurodegeneration has been clarified through the identification of mutations in the Tau gene in cases with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Although the mechanisms by which these mutations lead to nerve cell death are only incompletely understood, it is clear that they cause the formation of tau filaments with distinct morphologies and isoform compositions. The range of tau pathology identified in FTDP-17 recapitulates that in sporadic tauopathies, indicating a major role for tau dysfunction in these diseases. </description>
    </item> <item>
      <title>Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22 (Article)</title>
      <link>http://repub.eur.nl/res/pub/9764/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Hereditary frontotemporal dementia (FTD) is an autosomal dominant
      neurodegenerative disorder that is associated with mutations in the tau
      gene and with the pathological accumulation of hyperphosphorylated tau
      protein in affected brain cells in about a quarter of cases. However, most
      FTD families have no demonstrable tau mutations. Here we describe the
      clinical and neuropathological features of a large family with hereditary
      FTD. Genetic analysis showed strong evidence for linkage to chromosome
      17q21-22 (maximum lod score 3.46, theta = 0 for marker D17S950), but
      mutations in the tau gene were not found. Clinical symptoms,
      neuropsychological deficits and neuroimaging findings of affected family
      members were similar to sporadic and tau-related FTD. The mean age at
      onset was 61.2 years, with loss of initiative and decreased spontaneous
      speech as the most prominent presenting symptoms. Pathological examination
      of the brains of two affected family members showed non-specific neuronal
      degeneration with dense cytoplasmic ubiquitin-positive inclusions in
      neurones of the second layer of the frontotemporal cortex and dentate
      gyrus of the hippocampus. In a number of neurones these inclusions
      appeared to be located inside the nucleus, although due to the small
      number of these inclusions this localization could not be confirmed by
      electron microscopy. The inclusions were not stained by tau,
      alpha-synuclein or polyglutamine antibodies. Biochemical analysis of
      soluble tau did not reveal abnormalities in tau isoform distribution and
      analysis of mRNA showed the presence of both three- and four-repeat
      transcripts. This is the first report of ubiquitin-positive, tau-negative
      inclusions in an FTD family with significant linkage to chromosome
      17q21-22. Further characterization of the ubiquitin-positive inclusions
      may clarify the neurodegenerative pathways involved in this subtype of
      FTD.</description>
    </item>
  </channel>
</rss>